(Q51135801)

English

Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in Taiwan.

scientific article published in September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/16959618

Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in Taiwan. (English)

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/16959618

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

author name string

Jeng-Yuan Hsu

1

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/16959618

Reury-Perng Perng

2

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/16959618

Jau-Yeong Lu

3

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/16959618

Chin-Pyng Wu

4

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/16959618

Ming-Shyan Huang

5

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/16959618

Kwen-Tay Luh

6

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/16959618

Pan-Chyr Yang

7

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/16959618

publication date

1 September 2006

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/16959618

Journal of the Formosan Medical Association

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/16959618

105

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/16959618

708-714

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/16959618

9

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/16959618

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960198-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960198-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticholinergic, Antimuscarinic Bronchodilators1,2

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960198-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Muscarinic receptor subtypes in airways

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960198-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960198-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960198-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960198-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960198-4

7 January 2021

based on heuristic

inferred from DOI database lookup

One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960198-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960198-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Atropine on Velocity of Tracheal Mucus in Anesthetized Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960198-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of inhaled tiotropium bromide on lung mucociliary clearance in patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960198-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of salmeterol xinafoate in the treatment of COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960198-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960198-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960198-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2809%2960198-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0929-6646(09)60198-4

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/16959618

1 reference

Europe PubMed Central

30 March 2018

http://europepmc.org/abstract/MED/16959618

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51135801&oldid=1411806944"